Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 6/20 | 0.85 |
| ▸ | CNR1 | P21554 | 5/20 | 0.85 |
| ▸ | PTGS2 | P35354 | 10/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.60 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6753402 | 0.89 | CNR1 (0.83) | CNR2CNR1PTGS2HIF1AHTR1A | |
| SCHEMBL12988768 | 0.85 | PTGS2 (0.86) | CNR2PTGS2HIF1AHTR1APKM | |
| SCHEMBL29855593 | 0.85 | PTGS2 (0.86) | CNR2PTGS2HIF1AHTR1APKM | |
| SCHEMBL8932650 | 0.81 | CNR2 (1.00) | CNR2CNR1PTGS2HIF1APKM | |
| SCHEMBL8932634 | 0.81 | CNR2 (0.88) | CNR2CNR1PTGS2PKMCYP1A2 | |
| SCHEMBL5801098 | 0.81 | CNR1 (0.73) | CNR2CNR1PTGS2HIF1APTGS1 | |
| SCHEMBL11149891 | 0.79 | PTGS2 (0.76) | CNR2PTGS2HIF1AHTR1APKM | |
| SCHEMBL29355098 | 0.79 | PTGS2 (0.82) | CNR2PTGS2HIF1AHTR1APKM | |
| SCHEMBL10518353 | 0.78 | PTGS2 (0.69) | CNR2CNR1PTGS2HIF1AHTR1A | |
| SCHEMBL4549122 | 0.78 | PTGS2 (1.00) | CNR2PTGS2HIF1AHTR1APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118330991-A | Composition for forming resist underlayer film, pattern forming method, and method for forming resist underlayer film | 信越化学工业株式会社 | 2024-07-12 | — | — | CN | disclosed |
| US-20240019782-A1 | Composition For Forming Metal Oxide Film, Patterning Process, And Method For Forming Metal Oxide Film | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-18 | — | — | US | disclosed |
| EP-4303657-A2 | COMPOSITION FOR FORMING METAL OXIDE FILM, PATTERNING PROCESS, AND METHOD FOR FORMING METAL OXIDE FILM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-10 | — | — | EP | disclosed |
| CN-117363058-A | Composition for forming metal oxide film, pattern forming method, and metal oxide film forming method | 信越化学工业株式会社 | 2024-01-09 | — | — | CN | disclosed |
| CN-117024997-A | Composition for forming metal oxide film, pattern forming method, and metal oxide film forming method | 信越化学工业株式会社 | 2023-11-10 | — | — | CN | disclosed |
| CN-116661242-A | Planarization agent for forming organic film, composition for forming organic film, method for forming organic film, and method for forming pattern | 信越化学工业株式会社 | 2023-08-29 | — | — | CN | disclosed |
| CN-104725620-A | Unsaturated polylactic acid segmented copolymer and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY | 2015-06-24 | — | — | CN | disclosed |
| CN-101616975-B | Mixtures of n-alkanols and their use | BASF SE | 2014-08-06 | — | — | CN | disclosed |
| CN-101616975-A | The mixture of n-alkanols and their purposes | BASF SE | 2009-12-30 | — | — | CN | disclosed |
| US-20090186859-A1 | DIAZENIUMDIOLATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, COMPOSITIONS THEREOF, AND RELATED METHODS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SEC., DEPT. OF HEALTH AND HUMAN SERVICES (MD) | 2009-07-23 | — | — | US | disclosed |
| EP-2039718-A2 | Quickly coagulating softener preparations | Lanxess Deutschland GmbH (DE) | 2009-03-25 | — | — | EP | disclosed |
| EP-2010486-A2 | DIAZENIUMDIOLATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, COMPOSITIONS THEREOF, AND RELATED METHODS | The Government Of The United States Of America As Representative National Institutes of Health (US) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007127725-A2 | DIAZENIUMDIOLATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, COMPOSITIONS THEREOF, AND RELATED METHODS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186859-A1 | DIAZENIUMDIOLATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, COMPOSITIONS THEREOF, AND RELATED METHODS | NOS2, NOS1, NOS3 | CNR2 230/4885CNR1 337/4885PTGS2 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.